FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Westervelt

Research Profile

Disorders

Chemicals & Drugs

Procedures

Living Beings

Physiology

Mutation

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Ali McBride; Kristan M Augustin; Leigh Boehmer; Sara K Butler; Sherrie C Lathon; Peter Westervelt
Comparative evaluation of single fixed dosing and weight-based dosing of rasburicase for tumor lysis syndrome.
G Ramsingh; Keith E Stockerl-Goldstein; G L Uy; Camille N Abboud; N Bernabe; Amanda F Cashen; John F DiPersio; R Monahan; Peter Westervelt; Ravi Vij
A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML.
Ali McBride; Julie Nobbe; Kristan M Augustin; Peter Westervelt
Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Westervelt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ali McBride; Kristan M Augustin; Leigh Boehmer; Sara K Butler; Sherrie C Lathon; Peter Westervelt
Comparative evaluation of single fixed dosing and weight-based dosing of rasburicase for tumor lysis syndrome.
Pharmacotherapy 2013;33(3):295-303.
2013: G Ramsingh; Keith E Stockerl-Goldstein; G L Uy; Camille N Abboud; N Bernabe; Amanda F Cashen; John F DiPersio; R Monahan; Peter Westervelt; Ravi Vij
A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML.
Leukemia 2013;27(3):725-8.
2012: Ali McBride; Julie Nobbe; Kristan M Augustin; Peter Westervelt
Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemia.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2012;18(3):360-5.
2012: J S Chawla; John F DiPersio; A Ghobadi; J Mosley; Keith E Stockerl-Goldstein; Kathryn Trinkaus; G L Uy; L Verkruyse; Camille N Abboud; Amanda F Cashen; Peter Westervelt; Ravi Vij
Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literature.
Transplant infectious disease : an official journal of the Transplantation Society 2012;14(3):259-67.
2012: Geoffrey L Uy; Ravi Vij; Peter Westervelt; Camille N Abboud; Amanda F Cashen; Lindsay M Hladnik; Shashikant Kulkarni; Kyle McFarland; Ibraheem H Motabi; Michael P Rettig; Keith E Stockerl-Goldstein; Kathryn Trinkaus; John F DiPersio
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.
Blood 2012;119(17):3917-24.
2012: Matthew J Walter; Peter Westervelt; Richard K Wilson; Sarah Witowski; Rachel Abbott; Ken Chen; Li Ding; John F DiPersio; David Dooling; William Eades; Xian Fan; John L Frater; Robert Fulton; Marcus Grillot; Sharon Heath; Joelle Kalicki-Veizer; Daniel C Koboldt; David E Larson; Timothy J Ley; Daniel C Link; vincent magrini; Elaine R Mardis; Michael D McLellan; Michelle O'Laughlin; Heather Schmidt; Jin Shao; Dong Shen; Michael H Tomasson; Timothy A Graubert
Clonal architecture of secondary acute myeloid leukemia.
The New England journal of medicine 2012;366(12):1090-8.
2011: Jacob P Smeltzer; Keith E Stockerl-Goldstein; Geoffrey L Uy; Ravi Vij; Peter Westervelt; Qin Zhang; Camille N Abboud; Nancy L Bartlett; Amanda F Cashen; Farrokh Dehdashti; John F DiPersio; Andrew Homb; Todd A Fehniger
Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(11):1646-52.
2011: John S Welch; Peter Westervelt; Camille N Abboud; Amanda F Cashen; John F DiPersio; Feng Gao; Anjum Hassan; Jeffery M Klco; Elizabeth Procknow; Keith E Stockerl-Goldstein; Geoffery L Uy; Ravi Vij
Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study.
American journal of hematology 2011;86(9):796-800.
2011: Jeffrey Crawford; Mark L Heaney; Sally Htoy; Susan Hudock; Dwight D Kloth; David J Kuter; Gary H Lyman; Brandon McMahon; David P Steensma; Saroj Vadhan-Raj; Peter Westervelt; Michael Westmoreland; Jeffrey Allen; James Armitage; Douglas W Blayney; Spero R Cataland
Myeloid growth factors.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(8):914-32.
2011: Matthew J Walter; Peter Westervelt; Richard K Wilson; J Baty; L Ding; John F DiPersio; Robert S Fulton; M Grillot; J Kalicki-Veizer; C Kandoth; Timothy J Ley; Elaine R Mardis; Michael D McLellan; M O'Laughlin; H Schmidt; J Shao; D Shen; Timothy A Graubert
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.
Leukemia 2011;25(7):1153-8.
2011: John S Welch; Peter Westervelt; Li Ding; David E Larson; Jeffery M Klco; Shashikant Kulkarni; John Wallis; Ken Chen; Jacqueline E Payton; Robert S Fulton; Joelle Veizer; Heather Schmidt; Tammi L Vickery; Sharon Heath; Mark A Watson; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Timothy J Ley; Richard K Wilson
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.
JAMA : the journal of the American Medical Association 2011;305(15):1577-84.
2011: Todd A Fehniger; Geoffrey L Uy; Kathryn Trinkaus; Alissa D Nelson; Jeffery Demland; Camille N Abboud; Amanda F Cashen; Keith E Stockerl-Goldstein; Peter Westervelt; John F DiPersio; Ravi Vij
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia.
Blood 2011;117(6):1828-33.
2010: Bryan T Alexander; Lindsay M Hladnik; Kristan M Augustin; Ed Casabar; Peggy S McKinnon; Richard Reichley; David J Ritchie; Peter Westervelt; Erik R Dubberke
Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients.
Pharmacotherapy 2010;30(6):554-61.
2009: Mike G Martin; Kristan Augustin; Geoffrey L Uy; John S Welch; Lindsay Hladnik; Sagun Goyal; Divya Tiwari; Ryan S Monahan; Richard Reichley; Amanda F Cashen; Keith E Stockerl-Goldstein; Peter Westervelt; Camille N Abboud; John F DiPersio; Ravi Vij
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
American journal of hematology 2009;84(11):733-7.
2009: Mike G Martin; Richard A Walgren; Elizabeth Procknow; Geoffrey L Uy; Keith Stockerl-Goldstein; Amanda F Cashen; Peter Westervelt; Camille N Abboud; Friederike H Kreisel; Kristan Augustin; John F DiPersio; Ravi Vij
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.
American journal of hematology 2009;84(9):560-4.
2009: Matthew J Walter; Jacqueline E Payton; Rhonda E Ries; William D Shannon; Hrishikesh Deshmukh; Yu Zhao; Jack Baty; Sharon Heath; Peter Westervelt; Mark A Watson; Michael H Tomasson; Rakesh Nagarajan; Brian P O'Gara; Clara D Bloomfield; Krzysztof Mrózek; Rebecca R Selzer; Richmond Todd; Jacob Kitzman; Joel Geoghegan; Peggy S Eis; Rachel Maupin; Robert S Fulton; Michael D McLellan; Richard K Wilson; Elaine R Mardis; Daniel C Link; Timothy A Graubert; John F DiPersio; Timothy J Ley
Acquired copy number alterations in adult acute myeloid leukemia genomes.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(31):12950-5.
2008: Zhifu Xiang; Zhifu Xiang; Richard Walgren; Yu Zhao; Yumi Kasai; Tracie Miner; Rhonda E Ries; Olga Lubman; daved fremont; Michael D McLellan; Jacqueline E Payton; Peter Westervelt; John F DiPersio; Daniel C Link; Matthew J Walter; Timothy A Graubert; Mark Watson; Jack Baty; Sharon Heath; William D Shannon; Rakesh Nagarajan; Clara D Bloomfield; Elaine R Mardis; Richard K Wilson; Timothy J Ley
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.
Blood 2008;111(9):4797-808.
2007: Daniel C Link; Ghada Kunter; Yumi Kasai; Yu Zhao; Tracie Miner; Michael D McLellan; Rhonda E Ries; Deepak Kapur; Rakesh Nagarajan; David C Dale; Audrey Anna Bolyard; Laurence A Boxer; Karl Welte; Cornelia Zeidler; jean donadieu; Christine Bellanné-Chantelot; James W Vardiman; Michael A Caligiuri; Clara D Bloomfield; John F DiPersio; Michael H Tomasson; Timothy A Graubert; Peter Westervelt; Mark Watson; William D Shannon; Jack Baty; Elaine R Mardis; Richard K Wilson; Timothy J Ley
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
Blood 2007;110(5):1648-55.
2007: Jeffrey Crawford; Betsy Althaus; James Armitage; Lodovico Balducci; Charles L Bennett; Douglas W Blayney; Spero R Cataland; David C Dale; George D Demetri; Harry P Erba; James Foran; Alison G Freifeld; Mark L Heaney; Sally Htoy; Dwight D Kloth; Gary H Lyman; Wells A Messersmith; Laura Boehnke Michaud; Sarah C Miyata; Amy Robbins; Martin S Tallman; Saroj Vadhan-Raj; Peter Westervelt; Michael K Wong
Myeloid growth factors. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(2):188-202.
2005: Paul A Carpenter; James Lowder; Laura Johnston; Haydar Frangoul; Hanna Khoury; Pablo Parker; Keith R Jerome; Jeannine S McCune; Barry Storer; Paul Martin; Frederick R Appelbaum; Rafat Abonour; Peter Westervelt; Claudio Anasetti
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):465-71.
2003: Peter Westervelt; Andrew A Lane; Jessica L Pollock; Kristie Oldfather; Matthew S Holt; Drazen Zimonjic; Nicholas C Popescu; John F DiPersio; Timothy J Ley
High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression.
Blood 2003;102(5):1857-65.
2002: Peter Westervelt; Jessica L Pollock; Kristie M Oldfather; Matthew J Walter; Margaret K Ma; Anthony Williams; John F DiPersio; Timothy J Ley
Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(14):9468-73.
2002: Margaret K Ma; howard mcleod; Peter Westervelt; Paula M Fracasso
Pharmacokinetic study of infusional valspodar.
Journal of clinical pharmacology 2002;42(4):412-8.
2002: William Blum; Randy Brown; Hsu-san Lin; B Zehnbauer; Hanna Khoury; Lawrence T Goodnough; Peter Westervelt; Ravi Vij; John DiPersio; Douglas Adkins
Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(11):608-18.
2001: Peter Westervelt; Randy A Brown; Douglas Adkins; Hanna Khoury; P Curtin; D Hurd; S M Luger; Margaret K Ma; Timothy J Ley; John F DiPersio
Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide.
Blood 2001;98(2):266-71.
2001: Jessica L Pollock; Peter Westervelt; Matthew J Walter; Andrew A Lane; Timothy J Ley
Mouse models of acute promyelocytic leukemia.
Current opinion in hematology 2001;8(4):206-11.
2001: Hanna Khoury; Ashwin Kashyap; Douglas Adkins; Randy A Brown; G Miller; Ravi Vij; Peter Westervelt; Kathryn Trinkaus; Lawrence T Goodnough; R J Hayashi; Pablo Parker; Stephen J Forman; John F DiPersio
Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin.
Bone marrow transplantation 2001;27(10):1059-64.
2001: Hanna Khoury; Douglas Adkins; Robert Brown; H Pence; Ravi Vij; Lawrence T Goodnough; Peter Westervelt; Kathryn Trinkaus; Hsu-san Lin; Y DiPersio
Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(6):352-8.
2000: Douglas Adkins; Muneer H Abidi; Randy A Brown; Hanna Khoury; Lawrence T Goodnough; Ravi Vij; Peter Westervelt; John F DiPersio
Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
Bone marrow transplantation 2000;26(11):1239-41.
2000: Drazen Zimonjic; Jessica L Pollock; Peter Westervelt; Nicholas C Popescu; Timothy J Ley
Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(24):13306-11.
2000: Hanna Khoury; Douglas Adkins; Robert Brown; Ravi Vij; Peter Westervelt; Kathryn Trinkaus; Lawrence T Goodnough; John F DiPersio
Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation.
Bone marrow transplantation 2000;25(11):1197-201.
2000: Paula M Fracasso; Peter Westervelt; Carole L Fears; DM Rosen; Eleanor G Zuhowski; L A Cazenave; Litchman Manuel; Merrill J Egorin; P Westerveldt; C A Fears
Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):1124-34.
1999: Jessica L Pollock; Peter Westervelt; A K Kurichety; P G Pelicci; Jay L Grisolano; Timothy J Ley
A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(26):15103-8.
1999: Peter Westervelt; Timothy J Ley
Seed versus soil: the importance of the target cell for transgenic models of human leukemias.
Blood 1999;93(7):2143-8.